Compare · ECL vs YCBD
ECL vs YCBD
Side-by-side comparison of Ecolab Inc. (ECL) and cbdMD Inc. (YCBD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ECL and YCBD operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- ECL is the larger of the two at $81.52B, about 20215.3x YCBD ($4.0M).
- Over the past year, ECL is up 4.5% and YCBD is down 70.7% - ECL leads by 75.2 points.
- ECL has been more active in the news (14 items in the past 4 weeks vs 1 for YCBD).
- ECL has more recent analyst coverage (25 ratings vs 0 for YCBD).
- Company
- Ecolab Inc.
- cbdMD Inc.
- Price
- $288.81-0.64%
- $0.34-4.28%
- Market cap
- $81.52B
- $4.0M
- 1M return
- +6.28%
- -28.37%
- 1Y return
- +4.51%
- -70.71%
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NYSE
- AMEX
- IPO
- 2017
- News (4w)
- 14
- 1
- Recent ratings
- 25
- 0
Ecolab Inc.
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services worldwide. Its Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, and petrochemical industries. The company's Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in St. Paul, Minnesota.
cbdMD Inc.
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. It owns and operates consumer hemp-based CBD brands, such as cbdMD and Paw CBD. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. It distributes its products through its e-commerce Website, third party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was founded in 2015 and is headquartered in Charlotte, North Carolina.
Latest ECL
- Director Zillmer John J was granted 131 shares, increasing direct ownership by 0.27% to 49,540 units (SEC Form 4)
- Director Whalen Julie was granted 131 shares, increasing direct ownership by 28% to 604 units (SEC Form 4)
- Director Vautrinot Suzanne M was granted 131 shares, increasing direct ownership by 1% to 11,960 units (SEC Form 4)
- Director Nowell Lionel L Iii was granted 131 shares, increasing direct ownership by 2% to 6,922 units (SEC Form 4)
- Director Mckibben Tracy B was granted 131 shares, increasing direct ownership by 1% to 11,821 units (SEC Form 4)
- Director Maclennan David was granted 178 shares, increasing direct ownership by 0.70% to 25,625 units (SEC Form 4)
- Director Larson Michael was granted 131 shares, increasing direct ownership by 0.68% to 19,326 units (SEC Form 4)
- Director Gross Marion K. was granted 131 shares, increasing direct ownership by 22% to 730 units (SEC Form 4)
- Director Green Eric Mark was granted 276 shares, increasing direct ownership by 3% to 8,234 units (SEC Form 4)
- Director Doukeris Michel D was granted 131 shares, increasing direct ownership by 2% to 8,590 units (SEC Form 4)
Latest YCBD
- Reserveage Launches Longev+ Exclusively at The Vitamin Shoppe, Bringing Strength Into the Healthy Aging Conversation
- cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness
- cbdMD Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026
- SEC Form 10-Q filed by cbdMD Inc.
- cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results
- cbdMD Applauds Proposed SENATE SPENDING BILL That Would Protect Access to Full-Spectrum CBD and Other Naturally Derived Hemp Products
- cbdMD Supports the Bipartisan Lawful Hemp Protection Act to Protect Consumers and Full-Spectrum CBD Access
- cbdMD's Oasis Brand Partners with Mexcor to Launch Into South Carolina
- cbdMD's Bluebird Botanicals Announces Official Partnership With Denver Audubon to Support Bird Conservation